Navigation Links
Cepheid to Present at the Robert W. Baird Growth Stock Conference and the Bank of America Healthcare Conference
Date:5/6/2008

SUNNYVALE, Calif., May 6 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) announced today that the Company will present at the following investor conferences:

-- The Robert W. Baird Growth Stock Conference on May 13 at 12:15 p.m. EDT

at The Four Seasons Hotel in Chicago

-- The Bank of America Healthcare Conference on May 14 at 3:40 p.m. EDT at

The Four Seasons Hotel in Las Vegas

John Bishop, Chief Executive Officer, and Andrew Miller, Senior Vice President, Chief Financial Officer, will provide a corporate overview at each conference.

Live webcasts, along with accompanying presentation slides, may be accessed on Cepheid's Web site at http://www.cepheid.com under Investors: Events: Webcasts and Presentations. A replay of the webcast presentations will be available for 90 days following the live events.

About Cepheid

Cepheid (Nasdaq: CPHD), based in Sunnyvale, California, is a molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as iden
'/>"/>

SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cepheid Schedules Teleconference and Webcast for First Quarter 2008 Results
2. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference
3. Cepheid Reports Fourth Quarter and Full Year 2007 Results
4. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
5. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
6. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
7. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
8. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
9. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
10. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
11. Cepheid to Present at Thomas Weisel Partners Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ll. You can think of it as origami very high-tec...inois have developed a technique for fabricating t...tures from thin films by coupling photolithography...teractions. , The films, only a few microns thick...e with thicker pieces of the same material. , "Th...
(Date:11/23/2009)...G,Mich.,Nov.23/PRNewswire-FirstCall/--NeogenCorpor...wder,Ph.D.,waselectedtoNeogen,sBoardofDirectorsatt..., Crowderhasmorethan40yearsofexperienceinthefood,a...nadjunctprofessorofagriculturaleconomicsatVirginia...dasUnitedStateschiefagriculturenegotiatorwiththera...
(Date:11/23/2009)...DCITY,Calif.,Nov.23/PRNewswire/--PearlTherapeutics...cproductsforthetreatmentofchronicrespiratorydiseas...mpany,sBoardofDirectors.Mr.Rosenhas25yearsofexperi...includingkeyrolesatGileadSciencesandALZACorporatio...rl,sBoardtosix. ,, "Howiebringsawealthofproduct...
(Date:11/20/2009)...ATTLE, Nov. 20 Dendreon ...the U.S. Food and Drug Administration (FDA) provid...ded Biologics License Application (BLA) for PROVEN...he FDA has assigned a Prescription Drug User Fee A...ill respond to Dendreon,s amended BLA. Dendreon i...
Breaking Biology Technology:Water droplets direct self-assembly process in thin-film materials 2Richard T. Crowder Joins Neogen's Board of Directors 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3
..., For purification of up to 10 mg ultrapure pla...ssic QIAGEN Plasmid Kits use gravity-flow anion-ex... plasmid DNA , , , , ..., , Purity equivalent ...n , , Reproducib...
..., For robust amplification in all applications,... , Component , Inclu... , , , ,... HotStarTaq DNA Polymerase, ,... PCR Buffer, , 10x sol...
..., R&D Department , QIAGEN GmbH, Hilden...expression profiling at the RNA level has been sig...ysis and quantitative real-time RT-PCR. Microarray...ng expression levels of hundreds or thousands , ...paration. Although real-time , PCR analysis...
Other Biology Technology:Critical factors for successful microarray and real-time PCR analyses 2Critical factors for successful microarray and real-time PCR analyses 3Critical factors for successful microarray and real-time PCR analyses 4Critical factors for successful microarray and real-time PCR analyses 5Critical factors for successful microarray and real-time PCR analyses 6Critical factors for successful microarray and real-time PCR analyses 7Critical factors for successful microarray and real-time PCR analyses 8
(Date:11/23/2009)...Washington, D.C. The community-associated strain ...cteria resistant to most common antibioticsposes a...nd is making its way into hospitals, according to ...ous Diseases . , The new threat is easily picke... places and has increased the overall burden of MR...
(Date:11/23/2009)... TORONTO, November 23, 2009 - The time of day mat...ng to a new paper produced by a research team led ...to Scarborough,s vice-principal for research and c...ology at the St. George campus. , Capitalizing...e poplar tree, the research team examined how popl...
(Date:11/23/2009)...IRVINE, Calif. -- More than 160 participants gathe...emies Keck FUTURES INITIATIVE conference. This yea...cientists, engineers, and medical researchers to e...ues surrounding the emerging field of synthetic bi...ar biology at Princeton University and this year,s...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Mercy Health Plans Launches MercyOne Connect 28TM 29 49874 1Mercy Health Plans Launches MercyOne Connect 28TM 29 49874 2Hard To Treat Diseases 28HTDS PK 29 To Regain Intellectual Property 28IP 29 Ownership 49873 1Hard To Treat Diseases 28HTDS PK 29 To Regain Intellectual Property 28IP 29 Ownership 49873 2Hard To Treat Diseases 28HTDS PK 29 To Regain Intellectual Property 28IP 29 Ownership 49873 3One Mans Mission to Improve Our Healthcare System and Resolve Chronic Pain 49871 1One Mans Mission to Improve Our Healthcare System and Resolve Chronic Pain 49871 2
...ly 1990s, federal agencies in the West were asked ...hat task involved an inventory and conservation pl...ssociated with old-growth forests. Debates arose a...daunting task and how best to carry it out., The ...Known Species, by Island Press, answers questions ...
...thy neurological function hinges on the efficient ... synapse. , Figuring out how the synapse traffics...ssion -- is crucial to understanding the function ... led by researchers at Weill Cornell Medical Colle...e to that puzzle. , Their findings, published tod...
...crobial life, yet the insects that feed on plants ...ding microorganisms they eat along with their gree...ss journal, BMC Biology shows how food-borne bacte...ors Dalial Freitak, David Heckel and Heiko Vogel f...in Jena, Germany along with Christopher Wheat from...
Other Biology News:A key enzyme helps keep the synapse on track 2A key enzyme helps keep the synapse on track 3Insect gut detects unhealthy meal 2
Acrylamide from GE Healthcare, formerly Amersham Biosciences
Assay Diluent Trial Pack from BioFX Laboratories, Inc.
...lone/PAD: ZMD.474. Immunogen: Synthetic peptide d...ophilin-3. Specificity: Specific for the internal...y: Mouse (positive controls: mouse brain homogenat...pplications: Western blotting Immunohistochemistry...
Rabbit Anti-Mouse Junctophilin-4, C-Terminus Monoclonal Antibody, Unconjugated, Clone PADZMD.487 from Invitrogen
Biology Products: